Pokes, pathogens, and primum non nocere: Prudent prophylaxis protocols for prostate biopsy

Infection Control and Hospital Epidemiology

Volumn 34, Issue 9, 2013, Pages 977-979

  Drawz, Sarah M ^a   Johnson, James R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM CULTURE; COST EFFECTIVENESS ANALYSIS; HUMAN; INFECTIOUS COMPLICATION; NOTE; PREVALENCE; PROSTATE BIOPSY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; MALE; PROSTATE; RECTUM;

EID: 84881174646     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/671937     Document Type: Note

References (17)

1. Nam RK, Saskin R, Lee Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010;183(3):963-968.
2. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. JUrol 2011;186(5):1830-1834.
3. Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 2013;57:267-274.
4. Zaytoun OM, Vargo EH, Rajan R, Berglund R, Gordon S, Jones JS. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 2011;77(5):1035-1041.
5. Liss MA, Peterson EM, Johnston B, Osann K, Johnson JR. Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology 2013;81(3):548-555.
6. Williamson DA, Roberts SA, Paterson DL, et al. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis 2012; 54(10):1406-1412.
7. Suwantarat N, Dumford DM III, Ponce-Terashima R, et al. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy. Infect Control Hosp Epidemiol 2013;34:973-976 (in this issue)
8. Duplessis CA, Bavaro M, Simons MP, et al. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 2012;79(3):556-561.
9. Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012;187(4):1275-1279.
10. Mosharafa AA, Torky MH, El Said WM, Meshref A. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 2011;78(3):511-514.
11. Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy: should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 2011;18(6):575-581.
12. Young JL, Liss MA, Szabo RJ. Sepsis due to fluoroquinoloneresistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 2009;74(2):332-338.
13. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ. Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis. Linthicum, MD: American Urological Association, 2008. http://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis.pdf. Accessed May 19, 2013
14. Zani EL, Clark OA, Rodrigues Netto N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 2011(5):CD006576.
15. Zaytoun OM, Anil T, Moussa AS, Jianbo L, Fareed K, Jones JS. Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors. Urology 2011; 77(4):910-914.
16. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157(2):120-134.
17. Carter HB, Albertsen PC, Barry MJ, et al. Early Detection of Prostate Cancer: AUA Guideline. Linthicum, MD: American Urological Association, 2013. https://www.auanet.org/common/pdf/education/clinical-guidance/Prostate-Cancer-Detection.pdf. Accessed May 19, 2013